Skip to main content
. 2020 Apr 27;146(7):1737–1749. doi: 10.1007/s00432-020-03228-4

Fig. 8.

Fig. 8

Gefitinib enhances the anti-tumor effect of cisplatin in H358R xenograft in vivo.a Tumor volume of xenograft tumors (H358R) treated with cisplatin, gefitinib, and cisplatin + gefitinib, respectively. b Growth curves of xenograft tumors (H358R) in each treatment group. c Body weight changes of model mouses in each treatment group during the treatment period